Selected article for: "acute kidney injury and administration acute kidney injury"
Author: Wysocki, Jan; Schulze, Arndt; Batlle, Daniel
Title: Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System
  • Document date: 2019_12_17
    • ID: 0vozochc_49
    Snippet: There are several potential indications of our small ACE2 variants for the treatment of kidney disease. In particular, we think that Acute Kidney Injury (AKI) may benefit from the administration of our small ACE2 variants as a way to calm down the kidney RAS, which is overactive in this clinical syndrome. The pathogenesis of AKI is complex, often involving hemodynamic and non-hemodynamic mechanisms [41] [42] [43] [44] . Alterations in the RAS hav.....
    Document: There are several potential indications of our small ACE2 variants for the treatment of kidney disease. In particular, we think that Acute Kidney Injury (AKI) may benefit from the administration of our small ACE2 variants as a way to calm down the kidney RAS, which is overactive in this clinical syndrome. The pathogenesis of AKI is complex, often involving hemodynamic and non-hemodynamic mechanisms [41] [42] [43] [44] . Alterations in the RAS have been shown to contribute to the development of AKI and are associated with adverse outcomes both in experimental and clinical studies [45] [46] [47] [48] [49] [50] . Several components of the kidney RAS, such as urine Angiotensinogen and Ang II, the main active peptide, are increased in experimental AKI caused by ischemia-reperfusion AKI [45] [46] [47] [51] [52] [53] [54] [55] [56] ACE inhibitors (ACEi) and angiotensin receptor antagonists (ARBs) may attenuate renal inflammation, injury and improve renal function in the ischemia-reperfusion model of AKI [57] [58] [59] [60] . Intrarenal Ang II is reportedly elevated in AKI, which may worsen kidney tissue injury independently of its hemodynamic effect that helps maintain renal circulation [61] [62] [63] . Based on these considerations, we are currently studying the effect of ACE2 1-619 in a mouse model of AKI.

    Search related documents:
    Co phrase search for related documents
    • ACE inhibitor and tissue injury: 1
    • ACEi ACE inhibitor and renal function: 1
    • active peptide and renal function: 1
    • active peptide and renal inflammation: 1, 2
    • adverse outcome and renal function: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adverse outcome and tissue injury: 1, 2, 3, 4
    • AKI development and renal function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • AKI development and renal inflammation: 1
    • AKI development and tissue injury: 1, 2
    • AKI pathogenesis and renal function: 1, 2
    • angiotensin receptor and RAS alteration: 1, 2
    • angiotensin receptor and renal function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • angiotensin receptor and renal inflammation: 1, 2, 3, 4, 5
    • angiotensin receptor and tissue injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical syndrome and renal function: 1, 2, 3, 4, 5, 6, 7
    • clinical syndrome and renal inflammation: 1
    • clinical syndrome and tissue injury: 1, 2, 3, 4, 5
    • injury renal inflammation and renal function: 1, 2
    • injury renal inflammation and renal inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10